Basics Neuronetics, Inc. Common Stock IPO Date: June 25, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $92.46M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.80% Avg Daily Range (30 D): $0.11 | 5.47% Avg Daily Range (90 D): $0.12 | 4.31% Institutional Daily Volume Avg Daily Volume: .37M Avg Daily Volume (30 D): 1.83M Avg Daily Volume (90 D): 1.48M Trade Size Avg Trade Size (Sh.): 151 Avg Trade Size (Sh.) (30 D): 206 Avg Trade Size (Sh.) (90 D): 183 Institutional Trades Total Inst.Trades: 155 Avg Inst. Trade: $1.89M Avg Inst. Trade (30 D): $.58M Avg Inst. Trade (90 D): $.76M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.49M Avg Closing Trade (30 D): $.58M Avg Closing Trade (90 D): $.58M Avg Closing Volume: 487.75K     News Oct 31, 2025 @ 8:30 PM Neuronetics Reports Inducement Grant Under Nasdaq ... Source: Neuronetics, Inc. Dec 10, 2024 @ 3:00 PM Neuronetics and Greenbrook TMS Announce Closing of... Source: N/A Jul 2, 2024 @ 2:40 PM Neuronetics (STIM) Expands NeuroStar Portfolio Wit... Source: Zacks Equity Research Jul 1, 2024 @ 12:02 PM NeuroStar® Launches Better Me Provider Program ... Source: Neuronetics Jun 13, 2024 @ 12:31 PM NeuroStar Showcases Cutting-Edge Research at Clini... Source: Neuronetics Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.83 $-.13 $-.15 Diluted EPS $-.83 $-.13 $-.15 Revenue $ 129.87M $ 37.3M $ 38.11M Gross Profit $ 65.5M $ 17.11M $ 17.76M Net Income / Loss $ -44.61M $ -9.4M $ -9.84M Operating Income / Loss $ -37.87M $ -7.32M $ -8.06M Cost of Revenue $ 64.38M $ 20.19M $ 20.35M Net Cash Flow $ 22.82M $ 17M $ -3.76M PE Ratio